FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2

Journal of Clinical Investigation

Volumn 117, Issue 12, 2007, Pages 3765-3773

  Zuo, Tao ^a,d   Liu, Runhua ^a   Zhang, Huiming ^a   Chang, Xing ^a   Liu, Yan ^a   Wang, Lizhong ^a   Zheng, Pan ^a,b,c   Liu, Yang ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Ohio State University ^*  (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE LOCUS; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CULLIN PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, X-LINKED; HETEROZYGOTE; HUMANS; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; ONCOGENE PROTEINS; PLOIDIES; RECEPTOR, ERBB-2; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 36849053106     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32538     Document Type: Article

References (33)

1. Vogelstein, B., and Kinzler, K.W. 2002. The genetic basis of human cancer. McGraw-Hill. New York, New York, USA/London, United Kingdom. 821 pp.
2. Macdonald, F., Ford, C.H.J., and Casson, A.G. 2004. Molecular biology of cancer. BIOS Scientific Publishers. London, United Kingdom/New York, New York, USA. 269 pp.
3. Huang, H., et al. 2005. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. U. S. A. 102:1649-1654.
4. Pagano, M. 2004. Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis. Mol. Cell. 14:414-416.
5. Nakayama, K.I., and Nakayama, K. 2006. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer. 6:369-381.
6. Schmidt, M., et al. 2002. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 22:7842-7852.
7. Zuo, T., et al. 2007. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of HER-2/ErbB2 oncogene. Cell. 129:1275-1286.
8. Nakayama, K., et al. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19:2069-2081.
9. Nakayama, K., et al. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell. 6:661-672.
10. Hara, T., et al. 2001. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 276:48937-48943.
11. Carrano, A.C., Eytan, E., Hershko, A., and Pagano, M. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199.
12. Traub, F., Mengel, M., Luck, H.J., Kreipe, H.H., and von Wasielewski, R. 2006. Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat. 99:185-191.
13. Sonoda, H., et al. 2006. Significance of skp2 expression in primary breast cancer. Clin. Cancer Res. 12:1215-1220.
14. Radke, S., Pirkmaier, A., and Germain, D. 2005. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene. 24:3448-3458.
15. Signoretti, S., et al. 2002. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J. Clin. Invest. 110:633-641. doi:10.1172/JCI200215795.
16. Latres, E., et al. 2001. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl. Acad. Sci. U. S. A. 98:2515-2520.
17. Shim, E.H., et al. 2003. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Cancer Res. 63:1583-1588.
18. Zhu, C.Q., et al. 2004. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin. Cancer Res. 10:1984-1991.
19. Zhang, L., and Wang, C. 2006. F-box protein Skp2: a novel transcriptional target of E2F. Oncogene. 25:2615-2627.
20. Imaki, H., et al. 2003. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res. 63:4607-4613.
21. Chatila, T.A., et al. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:R75-R81.
22. Brunkow, M.E., et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73.
23. Bennett, C.L., et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
24. Wildin, R.S., et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20.
25. Lin, W., et al. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8:359-368.
26. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
27. Fontenot, J.D., et al. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341.
28. Chang, X., et al. 2005. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J. Exp. Med. 202:1141-1151.
29. Marson, A., et al. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature. 445:931-935.
30. Zheng, Y., et al. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature. 445:936-940.
31. Giovarelli, M., et al. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155:3112-3123.
32. Im, H., et al. 2004. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol. Biol. 284:129-146.
33. Ji, P., et al. 2004. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. 16:47-58.